edetic acid has been researched along with melphalan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cunningham, D; Ellis, E; Gore, M; Mansi, J; Milan, S; Millar, J; Mundy, J; Smith, T; Viner, C | 1 |
| Crofts, M; Lopes, N; McElwain, TJ; Millar, JL; Mundy, J; Selby, PJ | 1 |
| Aalders, M; Beijnen, JH; Essers, M; Kuin, A; Lamfers, M; Smets, LA; van Zuidam, DJ | 1 |
1 review(s) available for edetic acid and melphalan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for edetic acid and melphalan
| Article | Year |
|---|---|
Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug scheduling.
Topics: Bone Marrow Transplantation; Chromium Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Edetic Acid; Gastrointestinal Diseases; Humans; Melphalan; Neoplasms | 1992 |
2 other study(ies) available for edetic acid and melphalan
| Article | Year |
|---|---|
Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy.
Topics: Adult; Bone Marrow Transplantation; Chromium Radioisotopes; Cyclophosphamide; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Intestinal Absorption; Intestinal Diseases; Intestinal Mucosa; Male; Melphalan; Middle Aged; Neoplasms; Time Factors | 1987 |
Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
Topics: 3-Iodobenzylguanidine; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Chlorambucil; Chromium Radioisotopes; Doxorubicin; Drug Synergism; Edetic Acid; Glucose; Guanidines; Hydrogen-Ion Concentration; Kidney; Leukemia L1210; Melphalan; Mice; Mitomycin; Tumor Cells, Cultured | 1999 |